Carmina Sirignano

Carmina Sirignano

Auto-generated profile, based on publicly available information

Carmina Sirignano

Department of Pharmacy, University of Naples Federico II, Naples, Italy

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2023 in Industrial Crops and Products
Verified
Journal Article
Closed access
Simona PiccolellaSimona Piccolella
Simona Piccolella
CSCarmina Sirignano
Carmina Sirignano
SPSeverina Pacifico
Severina Pacifico
EFElio Fantini
Elio Fantini
LDLoretta Daddiego
Loretta Daddiego
Daniela RiganoDaniela Rigano
Daniela Rigano

27 May 2026 in Phytomedicine
Verified
Journal Article
Open access
Massimiliano LucidiMassimiliano Lucidi
Massimiliano Lucidi
FIFrancesco Imperi
Francesco Imperi
MTMargherita Turi
Margherita Turi
MBMarta Beccarini
Marta Beccarini
SCSerena Ciolfi
Serena Ciolfi
Paolo ViscaPaolo Visca
Paolo Visca
There is an urgent need to develop new antibiotics to combat multidrug-resistant (MDR) Staphylococcus aureus infections. Amorfrutins are plant-derived prenylated benzoic acids whose antimicrobial potential is largely unexplored. This study aimed to investigate the antibacterial properties of amorfrutins. To this end, the antibacterial activity of ten amorfrutins purified from Glycyrrhiza foetida (Fabaceae) was evaluated by determining their minimum inhibitory concentrations (MICs) against reference bacterial strains, as well as their cytotoxicity in human cell lines. The most promising compound was investigated to identify its target, mode of action (MoA), interactions with standard-of-care anti-staphylococcal antibiotics, and inhibition of biofilm and persister cells. The MoA was corroborated by molecular dynamics simulations and in vitro assays using artificial membranes and cellular models. Toxicity and antibacterial efficacy were also assessed in an insect infection model. Among the tested amorfrutins, amorfrutin-A (AMF-A) exhibited the strongest activity against S. aureus (MIC=4-16 mg/L) without causing detectable cytotoxicity. AMF-A rapidly disrupted S. aureus membranes, eradicated biofilm and persister cells, and displayed an undetectable frequency of resistance development. AMF-A did not antagonize standard-of-care anti-staphylococcal antibiotics and showed synergistic effects with daptomycin, piperacillin, and azithromycin. AMF-A showed no in vivo toxicity and protected Galleria mellonella larvae from lethal S. aureus infection. We conclude that AMF-A is a promising membranolytic phytochemical with potential for treatment of MDR S. aureus infections.